# Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

> **NCT00575003** · PHASE2 · COMPLETED · sponsor: **Cytos Biotechnology AG** · enrollment: 64 (estimated)

## Conditions studied

- Perennial Allergy to House Dust Mite and/or Cat

## Interventions

- **DRUG:** CYT003-QbG10

## Key facts

- **NCT ID:** NCT00575003
- **Lead sponsor:** Cytos Biotechnology AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2009-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00575003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00575003, "Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00575003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*